The trial was halted due to inadequate efficacy, Jay Bradner, M.D., Amgen’s executive vice president of R&D, said during a Nov. 4 call with investors, after an ad hoc analysis requested by an internal ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

The world of sports is quickly changing, and you can see the change clearly in how teams use data to gain an edge. From ...

Snowflake is doubling down on agentic AI-rich tools with Snowflake Intelligence, Cortex AISQL and Snowflake ML to dominate ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide ...

Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...